Evaluation of Safety and Efficacy of Lumason in Pediatric Echocardiography

Summary

Safety and Efficacy Study in pediatric subjects aged 9 to 17 years of age with suboptimal LV EBD on non-contrast 2D echocardiography. Imaging modalities that are used throughout the study in pediatric subjects represented those utilized in routine clinical practice in adults.

Timeline

Start

2015-10

Primary completion

2018-05-31

Completion

2018-08

Drugs

Indications